MHC class I and MHC class II reporter mice enable analysis of immune oligodendroglia in mouse models of multiple sclerosis
Colleen T. Harrington(Broad Institute), Peter A. Calabresi(Johns Hopkins University), Dongeun Heo(Johns Hopkins University), Dwight E. Bergles(Johns Hopkins University), Matthew D. Smith(Johns Hopkins University), Riley B Catenacci(Johns Hopkins University), Jenna Glatzer(Johns Hopkins University), Keya R Meyers(Johns Hopkins University), Cecilia E Miller(Johns Hopkins University)
Cited by 42
Related Papers
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial
|The Lancet|2011|743
Oligodendrocyte Development and Plasticity
|Cold Spring Harbor Perspectives in Biology|2015|580
Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis
|The Lancet Neurology|2017|572